AlphAIAlphAI — Financial news for AI agents
law.comSEP 231 min read$ABT

Critical Mass With Law.com’s Amanda Bronstad: MDL Panel Takes Up More Spinal Cord Stimulator Cases This Week, Edison International Could Face Trial Over Los Angeles Wildfire

Abbott Laboratories and Nevro are arguing against consolidating lawsuits over their spinal cord stimulators before the U.S. Judicial Panel on Multidistrict Litigation. Separately, a judge heard objections to a $7.25 billion settlement over Monsanto's Roundup pesticide.

Original reporting
law.com
Published Sep 23, 2026, 2:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 3:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Critical Mass With Law.com’s Amanda Bronstad: MDL Panel Takes Up More Spinal Cord Stimulator Cases This Week, Edison International Could Face Trial Over Los Angeles Wildfire — source image
Source · law.com
Decision brief

The 30-second read

$ABTNeutralLow
01

Why it matters

Both Abbott and Nevro face ongoing legal risk that could affect earnings forecasts and stock volatility.

02

Market read

Legal exposure for two major medical‑device firms may influence sector sentiment and short‑term price action.

03

What to watch

Potential insurance recoveries or third‑party settlements are not discussed.

Relevance 5/10Novelty 5/10Timing: this week

Background

Multidistrict Litigation (MDL) consolidates related federal cases to improve efficiency and consistency of rulings.

Company-level read

Ticker impact

$ABTNeutralMedium confidence
Context

Abbott Laboratories is appearing before the U.S. Judicial Panel on Multidistrict Litigation this week over spinal cord stimulator lawsuits.

Expected impact

moderate downside risk if adverse rulings or settlement terms are disclosed

Evidence & confidence

Legal proceedings can influence investor sentiment, but no outcome is known yet.

Market effects

Sector

Medical device sector may see heightened scrutiny of spinal cord stimulator products.

Regional

U.S. healthcare stocks could experience modest volatility.

Global

Limited to companies directly involved in the litigation.

Counterpoint

What could challenge this read

If the panel consolidates cases, it could lead to a quicker settlement, limiting long‑term damage.

Key entities

  • company
    Abbott Laboratories

    U.S. healthcare and medical device manufacturer.

  • company
    Nevro

    Medical device company specializing in spinal cord stimulation.

Read at source← All news

Related articles

SEP 21
$ABTMedAI 8/10

NC reaches settlement with Abbott over contaminated baby formula that led to 2022 shortage

North Carolina settled with Abbott Laboratories for $384M over contaminated baby formula, part of a broader agreement with 39 states and the federal government. Abbott, which produces over 40% of U.S. formula, was accused of selling unsafe products and concealing test results. The recall caused a 2022 shortage. North Carolina's share is $216K, earmarked for Medicaid and nutrition programs.

wral.com2 min
SEP 21
$ABTHighAI 8/10

Abbott Laboratories To Pay $385M Over Allegations Of Tainted Infant Formula

Abbott Laboratories will pay $385M to resolve allegations of tainted infant formula. The settlement includes $348.7M to the federal government and $35.5M to state Medicaid programs. California's share is over $15M. The allegations span 2018-2022, involving production conditions that risked microorganism contamination. Abbott recalled several formula brands in 2022, leading to a nationwide shortage.

patch.com2 min
SEP 20
$ABTLowAI 8/10

Sunday Edition: Sodium

Abbott Laboratories agreed to pay $384.9M to settle a DOJ case over a 2022 infant formula outbreak. The settlement doesn't determine liability. Pending lawsuits remain. No specific company was named in an E. coli and Salmonella outbreak linked to seed supplier Everything Sprouts LLC. Italy's hepatitis A outbreak affected 130 people, possibly from bivalve mollusks. UK small businesses show good food safety practices but low awareness of food crime.

foodsafetynews.com4 min
SEP 20
$ABTLow

State settles infant formula contamination lawsuit, more Health Headlines

Colorado will receive nearly $2 million from Abbott Laboratories as part of a $348 million settlement over allegations of misrepresenting the safety of its infant formula, with additional $35.5 million to be split among states. The lawsuit claimed Abbott failed to maintain safety standards and disclose contamination test results. The funds will be returned to Colorado's Medicaid program.

gjsentinel.com2 min
SEP 19
$ABTMedAI 8/10

Abbott Laboratories Pays 384 Million In Baby Formula Safety Settlement

Abbott Laboratories (ABT) will pay $384 million to settle a lawsuit alleging it failed to maintain safety standards in its baby formula manufacturing facilities from 2018 to 2022, according to New York Attorney General Letitia James. The settlement includes $348 million to the federal government and $35 million to a coalition of states, with New York receiving $9.3 million. The lawsuit claimed Abbott's practices put products at risk of contamination and misled safety inspectors.

wpdh.com2 min